Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Long-Term Investments (2023 - 2025)

Lexaria Bioscience's Long-Term Investments history spans 3 years, with the latest figure at $64013.0 for Q4 2025.

  • For Q4 2025, Long-Term Investments changed 0.0% year-over-year to $64013.0; the TTM value through Nov 2025 reached $64013.0, changed 0.0%, while the annual FY2025 figure was $64013.0, 0.69% up from the prior year.
  • Long-Term Investments for Q4 2025 was $64013.0 at Lexaria Bioscience, roughly flat from $64013.0 in the prior quarter.
  • Across five years, Long-Term Investments topped out at $64014.0 in Q4 2024 and bottomed at $48559.0 in Q3 2023.
  • The 3-year median for Long-Term Investments is $64013.0 (2025), against an average of $61743.1.
  • The largest annual shift saw Long-Term Investments soared 30.92% in 2024 before it decreased 0.0% in 2025.
  • A 3-year view of Long-Term Investments shows it stood at $48559.0 in 2023, then soared by 31.83% to $64014.0 in 2024, then dropped by 0.0% to $64013.0 in 2025.
  • Per Business Quant, the three most recent readings for LEXX's Long-Term Investments are $64013.0 (Q4 2025), $64013.0 (Q3 2025), and $64014.0 (Q2 2025).